SYNTEM

WIPO WIPO 2021

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke SYNTEM wurde als Wortmarke am 06.04.2021 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 17. Mai 2023

Markenform Wortmarke
Aktenzeichen 1614412
Länder Australien Kanada China Europäische Gemeinschaft Großbritannien Indien Japan
Basismarke US Nr. 90621300, 02. April 2021
Anmeldedatum 06. April 2021
Ablaufdatum 06. April 2031

Markeninhaber

12 Merrion Square
Dublin
IE

Markenvertreter

1000 TOWN CENTER, 22ND FLOOR SOUTHFIELD MI 48075 US

Waren und Dienstleistungen

05 Biological, medicinal and pharmaceutical preparations, namely, therapeutics for the treatment of infertility, genetic, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; diagnostic preparations for medical and clinical laboratory use; dietetic preparations, namely, nutritional supplements based on vitamins, minerals and probiotics; chemicals for use in medical laboratories, namely, diagnostic chemicals
41 Providing educational information about chemicals, pharmaceuticals, diagnostic and laboratory products as well as biochemical, biological, chemical, immunochemical and immunological compositions and preparations provided through a website and distributed via global computer network
42 Product development for others relating to pharmaceuticals, biopharmaceuticals, health care products and medical products; scientific and technological consulting services in the pharmaceutical industry, and research and design relating thereto; industrial analysis in the nature of product testing and research and industrial research in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; product development consultation; product research services, namely, providing analytical testing, biosafety testing, reporting and laboratory services for others; scientific and technical product development consulting and research services for the pharmaceutical industry; custom design and development of chemical reagents and biochemical assays; research and development services in the field of cancer immunotherapy; conducting clinical trials for others in the field of cancer immunotherapy; scientific and industrial research; engineering project management services, namely, development of pharmaceutical substances, providing know-how, information and consulting services in high throughput screening of chemicals during chemical analysis, chemical synthesis, toxicological and pharmaceutical research, genome target identification and validation, consulting services in production and development in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products, animal and human pharmacokinetic evaluations, consulting services by providing clinical development concepts; hosting an on-line computer databases featuring medical terminology, medical and pharmaceutical data and scientific, medical and pharmaceutical counseling information; planning, performing and evaluating scientific studies; services rendered in the laboratory and chemical area, namely, development of analytical methods and drug master files, reviewing standards and practices to assure compliance with pharmaceutical application and regulation requirements and consultation in the area of upscaling of laboratory processes; services relating to pharmaceutical preparations, namely, medical research
44 Providing information and counseling in healthcare; drawing up medical and pharmaceutical expert reports, documents and information; consultancy and information services relating to medical products, namely, providing medical information to patients, doctors and clients to ensure drug safety; consulting services rendered in the medical, pharmaceutical, and pharma-economy sector; services relating to pharmaceutical preparations, namely, providing healthcare and medical advice, disease management, patient support services, namely, providing information in printed form and via electronic means in the fields of oncology, metabolic and cardiovascular diseases or disorders, and diseases and disorders of the central nervous system
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
10. Mai 2023 2023/19 Gaz EM Ablehnung
28. Dezember 2022 2022/52 Gaz CA Ablehnung
23. Juni 2022 2022/25 Gaz JP Ablehnung
21. Februar 2022 2022/8 Gaz GB Ablehnung
15. Februar 2022 2022/8 Gaz IN Ablehnung
10. Februar 2022 2022/9 Gaz EM Ablehnung
14. Januar 2022 2022/5 Gaz CN Ablehnung
09. Dezember 2021 2021/49 Gaz AU Ablehnung
16. November 2021 2021/47 Gaz IN Ablehnung
06. April 2021 2021/36 Gaz US Eintragung

ID: 141614412